Email ID
Password
Scrip   
Novo Nordisk launches improved NovoSeven in India
06 November 2009
Anju Ghangurde

Novo Nordisk has launched a new room temperature-stable formulation of its recombinant Factor VIIa product NovoSeven for haemophilia with inhibitors in India. The improved formulation will be available as 1mg and 2mg strengths that can be used intravenously to stop bleeding in inhibitor patients....



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36